Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey

Table 2 Clinical characteristics of the ADHD and normative survey population

Characteristics	ADHD children (n = 910)*	Normative children (n = 995)^†
Responding parent
Female, n (%)	716 (79)	612 (61)
Male, n (%)	194 (21)	384 (39)
Age of the majority of respondents, years	38–47	40–44
Marital status of respondents
Single/never married/widowed, n (%)	92 (10)	88 (9)
Married/cohabiting, n (%)	655 (72)	780 (78)
Divorced/separated, n (%)	160 (18)	128 (13)
Number of children aged 6–18 years per household
1 child, n (%)	321 (35)	520 (52)
2 children, n (%)	375 (41)	333 (34)
>/= 3 children, n (%)	214 (24)	142 (14)
Number of children with ADHD per household
1 child, n (%)	430 (73)	N/A
> 1 child, n (%)	159 (27)	N/A
Gender of child
Male, n (%)	688 (76)	760 (76)
Female, n (%)	222 (24)	235 (24)
Mean age of child, years	11.4	12.0
Average age of ADHD diagnosis, years	6.4	N/A
Medication status for child with ADHD
Receiving stimulant medication, n (%)	350 (38)	N/A
6–8 hour medication	140 (40)	N/A
12-hour medication	210 (60)	N/A
Not receiving medication, n (%)	560 (62)	N/A
Length of time ADHD medication prescribed
3–6 months, n (%)	27 (8)	N/A
6–12 months, n (%)	52 (15)
> 1 year, n (%)	271 (77)

6–8 hour mediation consisted of long-acting medication taken once-daily or short short-acting medication taken twice-daily; 12-hour stimulant medication consisted of long-acting medication taken once-daily, short-acting medication taken three-times daily or a combination of long- and short-acting medication
*If > 1 ADHD child with ADHD in household, the survey was completed with reference to the eldest child
^†If > 1 child without ADHD in household, survey was also completed with reference to the eldest child
ADHD = attention-deficit/hyperactivity disorder; N/A = not applicable

ISSN: 1753-2000